How to Track Nootropic Effectiveness
Affiliate Disclosure: Some links on this page are affiliate links. If you purchase through them, NeuroEdge Formula earns a small commission at no extra cost to you. Peter only recommends products he has personally tested and that meet the evidence standards of this site.
Medical Disclaimer: This guide is for educational purposes only and does not constitute medical advice. It describes a self-tracking methodology, not a diagnostic tool — it cannot replace clinical assessment of cognitive function. If you have an underlying health condition, take medication, or are pregnant or breastfeeding, consult a qualified healthcare provider before introducing any new supplement. Peter Benson is a cognitive enhancement researcher, not a medical doctor.
| What this protocol measures | Whether a specific compound or stack produces a real, measurable change in cognition or wellbeing for you specifically — isolated from placebo response, day-to-day variation, and simple wishful thinking. |
| Minimum trial length | Four weeks for most compounds. Two weeks is sufficient for fast-acting stacks such as L-theanine and caffeine. Slow-build compounds — Lion’s Mane, Bacopa, Ashwagandha — often need six to eight weeks before a fair verdict is possible. |
| Core tools | A validated cognitive test battery (Creyos or equivalent), a structured daily journal with fixed rating scales, and — where relevant — objective corroborating data such as HRV or sleep tracking. |
| Baseline requirement | One to two weeks of data collection before introducing anything new. Without a baseline, there is nothing reliable to compare against, and every result becomes guesswork. |
| Most common mistake | Changing more than one variable at once, or judging a compound before its known onset window has passed — abandoning a slow-build compound at week two is the single most common wasted trial. |
| What running this protocol repeatedly teaches you | Subjective impression and objective test performance frequently disagree — sometimes in both directions. Measuring only one of them gives an incomplete, and occasionally wrong, answer. |
Most people decide whether a nootropic “worked” using the same method: they take it for a week or two, notice how they feel on a handful of days, and compare that fuzzy impression against an even fuzzier memory of how they felt before. It is, if you think about it for more than a few seconds, about as unreliable a measurement instrument as exists — vulnerable to mood, sleep debt, a stressful meeting, the placebo effect, and simple wishful thinking, all stacked on top of whatever the compound is actually doing.
In 18+ years of testing compounds on myself, I have learned — more than once, the hard way — that subjective impression and objective performance frequently disagree, sometimes in both directions. I have felt sharper on compounds that produced no measurable change on cognitive testing, and I have measured genuine improvement on compounds I would have sworn were doing nothing. The only way I have found to get a trustworthy answer, rather than a comforting story, is a structured protocol I now run before any new compound earns a permanent place in my stack. This guide is that exact protocol.
If you are still deciding what is actually worth testing in the first place, my complete Nootropics & Supplements guide is the right starting point. This article assumes you already have a candidate compound or stack in mind and want to know, honestly, whether it is doing anything.
Why “I Feel Different” Isn’t Good Enough
The expectation that a compound will work is itself a powerful driver of perceived — and sometimes measured — cognitive change. A study published in Frontiers in Psychiatry gave healthy adults a nasal spray they were told was either a cognitive enhancer or a performance-impairing substance, when in fact neither spray contained any active ingredient at all. Participants who expected enhancement reported feeling sharper; participants who expected impairment reported feeling worse — despite receiving an identical inert substance. The researchers describe this as a genuine placebo and nocebo effect operating specifically on cognitive self-assessment, not just on pain or mood, which is exactly the domain most nootropic testing happens in.
This matters enormously for anyone testing a supplement on themselves, because you are never a blinded participant. You know exactly what you took, when you took it, and what you are hoping it will do. Every one of those pieces of knowledge biases your subjective read on the result before you have collected a single data point. None of this means self-testing is worthless — it means self-testing needs structure that a casual “how do I feel today” check does not provide.
The formal name for a structured, single-person experiment is an N-of-1 trial. Once used almost exclusively in clinical settings to find the right treatment for an individual patient, N-of-1 methodology has increasingly been adapted for personal health tracking as digital tools have made data collection easier. Researchers building self-experimentation platforms describe the core requirement clearly: a genuine baseline period, a defined intervention period, and outcome measures decided in advance — before you know how the trial is going to turn out, not after.
Building a Real Baseline First
The single most commonly skipped step — and the one that quietly invalidates the most self-testing — is establishing a genuine baseline before introducing anything new. Cognitive performance is not a flat, stable line. It moves day to day with sleep quality, stress, hydration, illness, and factors you will never fully identify. Without at least one to two weeks of pre-trial data, you have no way of knowing whether a change you notice in week one of taking a compound reflects the compound or simply reflects the normal noise your cognition already produces.
A baseline period should use the exact same measurement tools you plan to use during the trial itself — the same cognitive test battery, the same journal questions, the same time of day. Run it for a minimum of one week, ideally two, before changing anything at all. If your baseline data already shows meaningful swings from day to day, that variability itself is useful information: it tells you how large a change needs to be, once you introduce a compound, before you can trust it as a real signal rather than ordinary fluctuation.
The Four-Week Protocol, Week by Week
Weeks -2 to 0 — Baseline
Run your chosen cognitive test at the same time of day, three to four times across this window. Complete a daily journal entry covering focus, mood, energy, and sleep quality on a simple 1–10 scale. Change nothing else about your existing supplement stack, sleep schedule, or exercise routine during this period — the goal is a clean, representative picture of your normal variation.
Weeks 1–2 — Introduction
Introduce the single compound or stack you are testing, at a consistent dose and time, and change nothing else. Continue the identical daily journal. This is the period where expectation bias is strongest, and where fast-acting compounds (caffeine-based stacks, for instance) will show their effect if they are going to show one at all. Slow-build compounds will typically show little to nothing yet — that is expected, not a failure.
Weeks 3–4 — Assessment
Repeat the cognitive test battery under the same conditions as your baseline sessions. This is where slow-build compounds most often reveal their effect, and where the gap between subjective journal entries and objective test scores becomes most informative — pay particular attention to cases where they disagree.
Week 4+ — Decision
Compare your week 3–4 test scores against your baseline average, not against a single baseline session. A genuine effect should show up as a sustained shift, not a one-off high score. From here there are three honest outcomes: continue if the data supports a real benefit, extend the trial by another two to four weeks if the compound has a plausible slow-build mechanism and the picture is still unclear, or discontinue if neither subjective nor objective measures show a meaningful change.
Choosing Your Measurement Tools
A validated computerised cognitive battery is the most reliable single tool available for this kind of testing, but it comes with one confound worth knowing about before you start: practice effects. Research evaluating a widely used computerised neuropsychological battery found that healthy adults scored measurably higher on several subtests — cognitive flexibility, processing speed, reaction time — simply from taking the test a second time, with no intervention at all, and that this improvement largely disappeared by the third administration. In practice, this means your first retest after baseline will always look somewhat better than it should on tests with a speed component, purely from familiarity, regardless of what you are taking. Building at least two baseline sessions, not one, into your protocol is the most direct way to account for this.
If a full cognitive battery like Creyos is more than you want to commit to, a structured daily journal with fixed rating scales is a reasonable substitute, provided the questions stay identical throughout the trial and you resist the temptation to add new questions once you start noticing something interesting — that is a subtle way expectation creeps back in.
Objective physiological data — HRV, sleep stage tracking — is not a direct measure of cognition, but it is a genuinely useful corroborating signal and an excellent confound detector. If your HRV trend drops sharply during a trial, that alone can explain a dip in test scores that has nothing to do with the compound you are testing.
Reading Your Results Honestly
A null result is a real answer, not a failed experiment. If four weeks of clean testing shows no meaningful shift in either your journal ratings or your cognitive scores, the honest conclusion is that the compound is not doing anything measurable for you specifically — not that you tested it wrong. This is one of the least comfortable but most valuable outcomes the protocol can produce, because it stops you from continuing to pay for, and take, something with no real effect.
Equally, treat a single unusually good test session with suspicion rather than excitement. Individual sessions are noisy. A real effect shows up as a sustained pattern across multiple sessions and multiple weeks, not a single standout score you happen to notice and remember.
Clinical Evidence: The Key Trials
Randomised Trial — Expectation and Cognitive Self-Report
The Placebo and Nocebo Study Behind This Whole Protocol
Healthy adults were given a nasal spray and randomly told it was either a cognitive enhancer or a performance-impairing substance — in reality, neither spray contained any active ingredient. Participants told to expect enhancement reported feeling sharper; participants told to expect impairment reported feeling worse, despite receiving an identical inert substance. The researchers describe this as a genuine placebo and nocebo effect operating specifically on cognitive self-assessment, not merely on mood or pain — precisely the domain most self-directed nootropic testing takes place in. This is the single strongest piece of evidence for why a structured protocol, not a felt impression, has to be the basis for any conclusion about a compound.
Methodology Research — Self-Experimentation Design
The N-of-1 Trial Framework This Protocol Is Built On
Researchers developing digital tools for personal N-of-1 trials — structured single-person experiments, historically used in clinical settings to find the right treatment for an individual patient — identified the same core requirements this guide’s four-week protocol is built around: a genuine baseline period collected before any change, a clearly defined intervention period, and outcome measures decided in advance, before the results are known, rather than chosen afterward to fit whatever pattern seems to have appeared. Without these three elements in that order, a self-experiment is vulnerable to exactly the same expectation and hindsight biases as an unstructured impression.
Reliability Study — Computerised Cognitive Testing
Rijnen et al. — Why Your First Retest Always Looks Better
A study evaluating a widely used computerised neuropsychological battery found that healthy adults scored measurably higher on several subtests — cognitive flexibility, processing speed, reaction time — simply from taking the same test a second time, with no intervention of any kind between sessions. This improvement largely disappeared by the third administration, indicating a genuine practice effect rather than a real change in ability. For anyone running the protocol in this guide, the practical implication is direct: your first retest after baseline will look somewhat better than it should on any timed subtest, purely from familiarity, which is exactly why the protocol calls for multiple baseline sessions rather than a single one.
Taken together, these three findings are the actual scientific basis for this protocol’s structure: expectation alone can shift cognitive self-report in either direction, structured self-experimentation requires baseline-then-intervention sequencing decided in advance, and even objective testing carries its own bias if you don’t account for practice effects. The protocol exists because each of these three failure modes is real and independently documented.
Measurement Methods — Ranked by Reliability
🟢 Highest reliability | 🟡 Useful secondary signal | 🔴 Lowest reliability
The Protocol in Practice
Composite profiles based on reader-reported experiences. Individual results vary.
Daniel, 33
Product manager who nearly gave up on a stack that was actually working
“I ran the L-theanine and caffeine stack for two weeks and honestly couldn’t tell you it felt any different from my normal coffee. I was ready to write it off. But I’d been running the Creyos battery every Sunday as part of the four-week protocol, and when I looked at the numbers instead of my gut feeling, my attention-switching scores had improved noticeably against my baseline fortnight. My subjective sense of focus turned out to be a poor instrument — the data disagreed with me completely. I kept going mainly out of curiosity about whether my own perception would ever catch up with what the testing was already showing.”
Testing: L-theanine + caffeine stack · Method: weekly Creyos vs. subjective log · Finding: objective gain despite no subjective change · Lesson: feeling is not a reliable instrument
Aisha, 27
Trainee solicitor who almost quit Lion’s Mane after two weeks
“When nothing happened in the first two weeks of my Lion’s Mane trial, I assumed it was one of those supplements that just doesn’t do anything for me. I nearly stopped there. Because the protocol runs a full four weeks before you’re allowed to make that call, I kept my daily journal going anyway. In week three I noticed I was retaining case details on the first read rather than going back over them twice. My Creyos verbal memory score at week four was up clearly against baseline, which matched what I’d started noticing. If I’d judged it at the two-week mark, the way I judge most things, I’d have missed it completely.”
Testing: Lion’s Mane, daily · Method: daily journal + week 4 Creyos comparison · Finding: no change until week 3, verbal memory gain by week 4 · Lesson: slow-build compounds need the full four weeks
Helen, 44
Marketing director who used the protocol to rule something out
“I’d read enough enthusiastic reviews of ashwagandha for stress that I was fairly convinced before I’d even started. I ran the full four weeks anyway — daily HRV readings, weekly Creyos, all of it. At the end, my HRV trend was flat against my pre-trial baseline and my processing speed scores hadn’t moved outside normal test-retest variation. Nothing. I’d expected the testing to simply confirm what I already believed, and instead it told me I’d been buying something that wasn’t doing anything measurable for my situation. Mildly annoying at the time, but it saved me from carrying on paying for it for no reason — which is exactly what this is supposed to do.”
Testing: ashwagandha for stress · Method: daily HRV + weekly Creyos over 4 weeks · Finding: no measurable change in HRV or processing speed · Lesson: the protocol’s job includes telling you what isn’t working
Omar, 39
Anaesthetist who wouldn’t trust a stack on feeling alone
“In my line of work, ‘I feel sharper’ isn’t a standard I’d act on, so when I wanted to try citicoline with L-theanine across a demanding rota, I wasn’t going to rely on impression. I ran the full protocol — a baseline week, then four weeks on the stack, with Creyos twice weekly rather than the standard once, because I wanted enough data points to trust the result. Reaction time and sustained attention scores both improved outside normal variation by week three. That’s the only reason I kept taking it — the numbers gave me a basis for confidence that a subjective impression never could have.”
Testing: citicoline + L-theanine · Method: baseline week + 4 weeks, Creyos twice weekly · Finding: reaction time and sustained attention improved by week 3 · Lesson: high-stakes decisions need objective, not subjective, evidence
The NeuroEdge Testing Protocol
The exact four-phase structure used to evaluate every compound before it earns a place in the recommended stacks on this site. Updated July 2026.
Same tools, same time of day, no changes. 3–4 cognitive test sessions plus daily journal entries. Change nothing else about your stack, sleep, or routine during this window.
One variable only. Introduce the compound or stack at a consistent dose and time. If you’d rather test a complete, pre-formulated stack than layer individual compounds one at a time, Mind Lab Pro gives you a single fixed variable to run through this exact protocol, rather than needing to isolate and test each ingredient separately.
Repeat testing under identical conditions. Compare against your baseline average, not a single session. Watch specifically for divergence between journal ratings and test scores.
Continue, extend, or discontinue. Continue if the sustained pattern supports a real effect. Extend by 2–4 weeks for plausible slow-build compounds with an unclear picture. Discontinue if neither measure shows a meaningful, sustained change.
Peter’s Testing Notes — How This Protocol Developed
18+ years personal research · Updated July 2026
This protocol did not arrive fully formed. For the first several years of testing compounds on myself, I relied on nothing more than a daily notebook entry and my own judgement — which, in hindsight, means most of my early conclusions were closer to guesses dressed up as findings. The turning point was adding a proper cognitive battery to the process. The first time I ran Creyos through a full baseline-and-trial cycle, I discovered that a stack I was convinced was helping my focus had produced no change whatsoever in processing speed or sustained attention over six weeks. What I was actually noticing, as far as I can tell, was the ritual of taking something new combined with paying closer attention to my own focus than usual.
I have now run some version of this exact four-phase structure well over sixty times across different compounds, and the pattern that surprises me most consistently is how often slow-build compounds get abandoned in week two by people — myself included, in the early years — who never gave them the full window. My own Bacopa trial showed nothing distinguishable from baseline until week five; by week seven, verbal memory recall on Creyos was up meaningfully and stayed up on retesting a month later. Had I judged it at week two, as I did with several other compounds before I built this protocol, I would have written it off entirely.
I track HRV through my Oura Ring alongside every trial now, specifically because it has caught confounds twice — once when a genuinely disappointing test week turned out to coincide with a poor sleep stretch that had nothing to do with what I was testing. That single addition has made me considerably more careful about attributing a bad week to a compound rather than to something else entirely.
Key Takeaways — Tracking Nootropic Effectiveness
Subjective impression alone is unreliable — expectation and placebo response measurably shape self-reported cognitive change, independent of whatever a compound is actually doing.
A one-to-two week baseline is non-negotiable — without it, there is nothing reliable to compare your trial results against.
Four weeks minimum, longer for slow-build compounds — abandoning a trial at two weeks is the single most common way real effects get missed.
Practice effects inflate early retest scores — build at least two baseline sessions into your protocol, not one, especially for speed-based cognitive tests.
A null result is a valid, useful outcome — the goal of testing is an honest answer, not a confirmation of what you hoped to find.
Tracking Nootropic Effectiveness — FAQ
Do I really need a cognitive test, or is a journal enough?
A structured journal is genuinely useful and far better than no tracking at all, but it captures only subjective impression, which research on expectation effects shows can shift independently of any real cognitive change. A validated cognitive battery adds an objective check that a journal cannot provide. If you can only commit to one, a consistent journal with fixed questions is a reasonable minimum; pairing it with periodic objective testing gives a materially more trustworthy result.
Why can’t I just compare how I feel now to how I felt before I started?
Memory of a past state is reconstructed, not recorded, and it is heavily coloured by what you currently expect or hope to find. Without contemporaneous baseline data collected before you started, the comparison is between a real, present measurement and an unreliable recollection — which is exactly the setup that makes placebo and expectation effects hardest to detect.
What if I don’t notice anything by week two — should I stop?
Not for most compounds. Fast-acting stacks like caffeine and L-theanine will typically show an effect quickly if they are going to; slow-build compounds such as Lion’s Mane, Bacopa, and Ashwagandha commonly show little to nothing at two weeks and only become measurable at four to eight weeks. Stopping early is the most common way a genuinely effective compound gets wrongly written off.
Can I test more than one compound at a time?
Not if you want a clear answer about either one individually. Introducing two or more new variables at once means any change you observe cannot be attributed to a specific compound. If you want to evaluate a complete multi-ingredient stack as a single unit — rather than each ingredient separately — that is a legitimate single variable, provided you do not add anything else on top of it during the trial.
My test scores went up in week one — doesn’t that prove it’s working?
Not on its own. Research on repeated cognitive testing consistently shows that scores on speed-based tests improve simply from familiarity the second time someone takes the same battery, independent of any intervention. This is exactly why the protocol calls for multiple baseline sessions rather than one, and why a genuine effect needs to appear as a sustained pattern across weeks three and four, not a single early improvement that practice effects alone could explain.
7 Days to a Sharper Brain
Peter Benson’s personal daily protocol, rebuilt from 18 years of testing
Seven evidence-based interventions, in the exact order that makes each one more effective — from sleep foundation to neuroplasticity and Lion’s Mane.
Join 2,000+ readers optimising their cognitive performance. Unsubscribe anytime.
Scientific References
- Rathschlag J, Foerster-Piotrowski C, et al. Placebo- and Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception. Frontiers in Psychiatry, 10:498 (2019). PMID 31354552
- Zenner AM, Böttinger E, Konigorski S. StudyMe: a new mobile app for user-centric N-of-1 trials. Trials, 23:466 (2022). PMC9793632
- Rijnen SJM, van der Linden SD, Emons WHM, Sitskoorn MM, Gehring K. Test-retest reliability and practice effects of a computerized neuropsychological battery: A solution-oriented approach. Psychological Assessment, 30(12):1652–1662 (2018). PMID 29952595
- Harvard Health Publishing. The power of the placebo effect. Harvard Medical School. Harvard Health
Peter Benson
Cognitive Enhancement Researcher | 18+ Years Independent Research
Peter Benson has run structured self-testing protocols on dozens of compounds over 18+ years, using Creyos cognitive testing and Oura Ring data to separate real effects from expectation and noise. This guide reflects the exact methodology he uses before recommending any compound on this site. He is not a clinician — this guide is educational, not medical advice.
Last reviewed: July 2026 | Educational content only. Not medical advice. Not a substitute for professional evaluation.
